Experimental endocarditis and fosfomycin.
The effectiveness of fosfomycin in combination with other antibiotics was studied in vitro and in the treatment of left-sided endocarditis in rabbits caused by S. sanguis, S. faecalis, S. aureus or P. aeruginosa. In vitro combinations of fosfomycin plus penicillin, fosfomycin plus cloxacillin, and fosfomycin plus amikacin were synergistic against the strains tested. In vivo synergism was also demonstrated since fosfomycin combinations produced a greater reduction in the number of CFU/g of vegetations than the administration of one antibiotic alone.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D005578:Fosfomycin / Q000627:therapeutic use*; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy; D013234:Stem Cells / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D005578:Fosfomycin